On the heels of the manufactured Covid-19 “pandemic”, consumers are rightly concerned about where their medical data is going. Genetic data may assist nefarious groups and people in creating biological weapons

The U.S. Department of Justice submitted a formal notice to the U.S. Bankruptcy Court for the Eastern District of Missouri, which is overseeing the Chapter 11 case of defunct 23andMe Holding Co. (Case No. 25-40976), warning that the potential sale of its assets—including a gigantic pool of millions of Americans' genetic data—may trigger a national security review by the Committee on Foreign Investment in the United States (CFIUS).

U.S. Attorney Sayler Fleming wrote in a filing that 23andMe is prohibited from selling the genetic data of more than 15 million customers to "covered persons.” “Covered persons” include companies classified as foreign entities that are 50% or more owned by entities based in countries viewed as problematic to U.S. interests, such as China, Russia, and North Korea.

Fleming's filing does not request the U.S. Bankruptcy Judge Brian Walsh to take action against any potential 23andMe transactions. The U.S. government is requesting that CFIUS review any sale of genetic data to ensure foreign adversaries are not utilizing any hidden methods to acquire the genetic data.

The sales of 23andMe is a national security priority as the huge pool of genetic data of Americans can be utilized to create precision bioweapons that can be designed to target specific genetic traits or ethnic groups as these groups tend to have shared DNA markers.

For example, a genetic virus could be altered to be targeted towards people of African descent.

James O'Keefe of O'Keefe Media Group caused a lot of fear when he released a video of an undercover journalist speaking with Nathaniel Johnson, a policy advisor in the U.S. Department of the Treasury. Johnson suggested that 23andMe may have already sold off users' genetic data: "Do not give your information to those people [23andMe]... they sell it to other people," Johnson said.

Johnson continued: "There's a clause in their contract, that basically says, like, we can give your information to our shareholders. So that they can do stuff. And all of their shareholders are, like pharmaceutical companies. But some of those pharmaceutical companies are based in other countries, and those pharmaceutical companies in other countries are like the property of, like the Ministry of Defense of Russia. Or, like, owned, by China."

What could possibly go wrong here? (Head shaking, rolling of eyes).